ATRC-101,Pembrolizumab
Atreca,merck
['solid tumor']
atreca presents data from ongoing phase 1b study of atrc-101 in patients with select advanced solid tumors at 2023 asco meeting $bcel
Options trader. Market-news. Nothing posted constitutes as advice. Do your own diligence.